Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • About HHS
  • Programs & Services
  • Grants & Contracts
  • Laws & Regulations
  • Radical Transparency
  • Big Wins
  • About OHRP
  • Regulations, Policy & Guidance
  • Education & Outreach
  • Compliance & Reporting
  • News & Events
  • Register IRBs & Obtain FWAs
  • SACHRP Committee
  • International
Breadcrumb
  1. HHS
  2. OHRP
  3. News
  4. Announcements & News Releases
  5. 2015 Announcements & News Releases
  6. OHRP and FDA Extend the Comment Period on the Draft Guidance
  • Announcements & News Releases
  • OHRP Newsletters
    • 2025 Newsletters
    • 2024 Newsletters
    • 2023 Newsletters
    • 2022 Newsletters
  • Sign up for Announcements
  • Events
  • Past Events
  • Federal Register Notices

OHRP and FDA Extend the Comment Period on the Draft Guidance on Minutes of IRB Meetings

December 14, 2015

The Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA) are extending the comment period for the joint draft guidance entitled “Minutes of Institutional Review Board (IRB) Meetings: Guidance for Institutions and IRBs.” A notice of availability requesting comments on the draft guidance document previously appeared in the Federal Register of November 5, 2015. The Agencies are taking the initiative to extend the comment period for an additional 30 days because the timing of the due date for comments intersects with comment periods on other Federal Register documents requiring review by the same group of stakeholders. This extension will allow interested persons additional time to submit comments. This joint draft guidance is available on OHRP’s website at http://www.hhs.gov/ohrp/regulations-and-policy/requests-for-comments/index.html, and on FDA's website at http://www.fda.gov/RegulatoryInformation/Guidances/ucm470046.htm. Comments are due by February 3, 2016

###
Like HHS on FacebookExit disclaimer icon, follow HHS on X @HHSgov Exit disclaimer icon, and sign up for HHS Email Updates Exit disclaimer icon.
Content created by Office for Human Research Protections (OHRP)
Content last reviewed December 14, 2015
Back to top

Subscribe to Email Updates

Receive the latest updates from the Secretary and Press Releases.

Subscribe
  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • Press Room
  • HHS Archive
  • Accessibility Statement
  • Privacy Policy
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov
  • Vulnerability Disclosure Policy
HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​

Follow HHS

Follow Secretary Kennedy